Patents by Inventor Xiaoxing Qiu

Xiaoxing Qiu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies to human immunodeficiency virus and uses thereof
    Publication number: 20050031624
    Abstract: The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.
    Type: Application
    Filed: September 14, 2004
    Publication date: February 10, 2005
    Inventors: Sheng Lou, Jeffrey Hunt, John Konrath, Xiaoxing Qiu, James Scheffel, Joan Tyner
  • Monoclonal antibodies to human immunodeficiency virus and uses thereof
    Publication number: 20050025772
    Abstract: The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.
    Type: Application
    Filed: September 14, 2004
    Publication date: February 3, 2005
    Inventors: Sheng Lou, Jeffrey Hunt, John Konrath, Xiaoxing Qiu, James Scheffel, Joan Tyner
  • Monoclonal antibodies to human immunodeficiency virus and uses thereof
    Patent number: 6818392
    Abstract: The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.
    Type: Grant
    Filed: December 6, 2000
    Date of Patent: November 16, 2004
    Assignee: Abbott Laboratories
    Inventors: Sheng C. Lou, Jeffrey C. Hunt, John G. Konrath, Xiaoxing Qiu, James W. Scheffel, Joan D. Tyner
  • Monoclonal antibodies to human immunodeficiency virus and uses thereof
    Publication number: 20040101831
    Abstract: The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.
    Type: Application
    Filed: November 17, 2003
    Publication date: May 27, 2004
    Inventors: Sheng C. Lou, Jeffrey C. Hunt, John G. Konrath, Xiaoxing Qiu, James W. Scheffel, Joan D. Tyner
  • Monoclonal antibodies to human immunodeficiency virus and uses thereof
    Publication number: 20020106636
    Abstract: The present invention relates to novel monoclonal antibodies which may be used in the detection of Human Immunodeficiency Virus (HIV). These antibodies exhibit an unusually high degree of sensitivity, a remarkably broad range of specificity, and bind to novel shared, non-cross-reactive epitopes. In particular, the monoclonal antibodies of the present invention may be utilized to detect HIV-1 antigen and HIV-2 core antigen in a patient sample.
    Type: Application
    Filed: December 6, 2000
    Publication date: August 8, 2002
    Inventors: Sheng C. Lou, Jeffrey C. Hunt, John G. Konrath, Xiaoxing Qiu, James W. Scheffel, Joan D. Tyner
  • Prostate specific antigen peptides and uses thereof
    Patent number: 6143509
    Abstract: The present invention relates to peptides which may be used, for example, in the detection of free and complexed Prostate Specific Antigen and thus in the diagnosis of prostate cancer.
    Type: Grant
    Filed: February 6, 1996
    Date of Patent: November 7, 2000
    Assignee: Abbott Laboratories
    Inventors: Barry Lee Dowell, Dominique P. Bridon, Xiaoxing Qiu, Hans Lilja, Timo Petteri Piironen, Mauno Antero Vihinen, Kim Sverker Immanuel Pettersson